US cancer centers of excellence strategies for increased inclusion of racial and ethnic minorities in clinical trials
JM Regnante, NA Richie, L Fashoyin-Aje… - Journal of oncology …, 2019 - ascopubs.org
PURPOSE: Participation of racial and ethnic minority groups (REMGs) in cancer trials is
disproportionately low despite a high prevalence of certain cancers in REMG populations …
disproportionately low despite a high prevalence of certain cancers in REMG populations …
[HTML][HTML] Operational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials
JM Regnante, N Richie, L Fashoyin-Aje, LL Hall… - Contemporary Clinical …, 2020 - Elsevier
Background Study populations in clinical research must reflect US changing demographics,
especially with the rise of precision medicine. However, racial and ethnic minority groups …
especially with the rise of precision medicine. However, racial and ethnic minority groups …
Five National Cancer Institute–designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: A current view and opportunities …
ET Hawk, EB Habermann, JG Ford, JA Wenzel… - Cancer, 2014 - Wiley Online Library
BACKGROUND To ensure that National Institutes of Health‐funded research is relevant to
the population's needs, specific emphasis on proportional representation of minority/sex …
the population's needs, specific emphasis on proportional representation of minority/sex …
Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials
MC Christian, EL Trimble - Cancer Epidemiology Biomarkers & Prevention, 2003 - AACR
Significant disparities exist in cancer incidence among racial and ethnic groups in the United
States (1). Cancer incidence and mortality rates by gender and race/ethnicity for the most …
States (1). Cancer incidence and mortality rates by gender and race/ethnicity for the most …
Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience
W McCaskill-Stevens, MM McKinney… - Journal of clinical …, 2005 - ascopubs.org
Purpose The National Cancer Institute's (NCI) Minority-Based Community Clinical Oncology
Program (MBCCOP) seeks to enhance minority participation in cancer clinical trials by …
Program (MBCCOP) seeks to enhance minority participation in cancer clinical trials by …
Twenty years post‐NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual …
MS Chen Jr, PN Lara, JHT Dang, DA Paterniti, K Kelly - Cancer, 2014 - Wiley Online Library
BACKGROUND The National Institutes of Health (NIH) Revitalization Act of 1993 mandated
the appropriate inclusion of minorities in all NIH‐funded research. Twenty years after this …
the appropriate inclusion of minorities in all NIH‐funded research. Twenty years after this …
Increasing racial and ethnic diversity in cancer clinical trials: an American Society of Clinical Oncology and Association of Community Cancer Centers joint research …
RA Oyer, P Hurley, L Boehmer… - Journal of Clinical …, 2022 - ascopubs.org
A concerted commitment across research stakeholders is necessary to increase equity,
diversity, and inclusion (EDI) and address barriers to cancer clinical trial recruitment and …
diversity, and inclusion (EDI) and address barriers to cancer clinical trial recruitment and …
Interventions to increase racial and ethnic minority accrual into cancer clinical trials: a systematic review
R Nouvini, PA Parker, CD Malling, K Godwin… - Cancer, 2022 - Wiley Online Library
Background Racial and ethnic minorities (REMs) continue to be underrepresented in clinical
trials despite the 1993 National Institutes of Health's Revitalization Act mandating the …
trials despite the 1993 National Institutes of Health's Revitalization Act mandating the …
Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians …
RW Durant, JA Wenzel, IC Scarinci, DA Paterniti… - Cancer, 2014 - Wiley Online Library
BACKGROUND The study of disparities in minority recruitment to cancer clinical trials has
focused primarily on inquiries among minority populations. Yet very little is known about the …
focused primarily on inquiries among minority populations. Yet very little is known about the …
Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer
Background Clinical trials that study cancer are essential for testing the safety and
effectiveness of promising treatments, but most people with cancer never enroll in a clinical …
effectiveness of promising treatments, but most people with cancer never enroll in a clinical …